 |
|
| AMYLIN, 52
| |
| | |
|
|
 Physiology and Pharmacology
To order this title, and for more information, click here
By
Andrew Young, Amylin Pharmaceuticals Inc., San Diego, CA, USA
Included in series
Advances in Pharmacology,
Description
Deciphers amylin's physiology and reveals previously unrecognized mechanisms fundamental to control body weight and fuel homeostasis.
Also discusses therapeutic utility of amylin as the first new medicine to treat diabetes since insulin.
Audience
Endocrinologists, pharmacologists, biochemists, neuroscientists
Contents
Section 1:
Chapter 1. Historical Background
Chapter 2. Tissue Expression and Secretion of Amylin
Chapter 3. Receptor Pharmacology
Section
2: Biological Action of Amylin
Chapter 4. Amylin and the Integrated control of Nutrient Influx
Chapter 5. Inhibition of Food Intake
Chapter 6. Inhibition of Gastric Emptying
Chapter 7: Effects on Digestive Secretions
Chapter 8. Inhibition of Glucagon Secretion
Chapter
9. Inhibition of Insulin Secretion
Chapter 10. Effects on Plasma Glucose and Lactate
Chapter 11. Effects in Skeletal Muscle
Chapter 12.
Effects in Liver
Chapter 13: Effects in Fat
Chapter 14. Cardiovascular Effects
Chapter 15. Renal Effects
Chapter 16. Effects on Bone
Chapter 17. Central Nervous System and Other Effects
Chapter 18. Clinical Studies
| Bibliographic details |
Hardbound, 360 pages, publication date: DEC-2005
ISBN-13: 978-0-12-032954-0
ISBN-10: 0-12-032954-9
Imprint: ACADEMIC PRESS
|
| Price and Ordering |
Price:
GBP 115
EUR 165
USD 225
|  |
Books and book related electronic products are priced in US dollars (USD), euro (EUR), and Great Britain Pounds (GBP). USD prices apply to the Americas and Asia Pacific. EUR prices apply in Europe and the Middle East. GBP prices apply to the UK and all other countries.
|
See also information about conditions of sale & ordering procedures, and links to our regional sales offices.
|
090/951
Last update: 27 Sep 2008
|
|
| |
| | |
|
|
| |
